ARCHIVES

Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

House Subcommittee Adds $30 Billion to NCI ’79 Budget

May 12, 1978

Utah, NIEHS Report Finding BRACA1 Gene For Familial Breast, Ovarian Cancer

September 23, 1994

NCA Approves New Guidelines For Comprehensive Review

December 8, 1989

Accrediting Agency Places Dana-Farber On Probation

April 21, 1995

FDA Approves SNDA For Gardasil For Anal Cancer And Precancerous Lesions

January 28, 2011

Colorectal Cancer Gene Carriers Seek Screening More Frequently, Study Finds

November 29, 2002